Pharmalot... Pharmalittle... Morning Edition

coffeeandpaper1.jpgA new week gets under way. And so this is an opportunity to catch up on events. Here are some worth noting....

Lundbeck Looking To Buy Other Companies In US (AFX/Thomson Financial)

Actavis Makes FDA Filing Challenging King Patent (MarketWatch)

India May Add More Drugs To Price-Controlled List (The Economic Times)

Teva Must Stop Selling Generic Famvir (Bloomberg News)

Cipla Sales Hurt By NGOs (BusinessWeek)